After the genomics gold rush comes pretomics

Article Abstract:

Proteomics is defined as being the characterization of relative abundance, all structures and functions, and the interactions of the complement of proteins in a given entity. By contrast, genomics is defined as obtaining and understanding the complement of genetic information available to a given organism. As such, proteomics is a subset of genomics. This article discusses changes brought about by recent research in both fields upon the other fields.

---

Drug target pharmacogenomics

Article Abstract:

The field of pharmacogenomics has as its goal to better understand the genetic contribution to that interpatient variability in drug response. This article provides an overview of this field, including current research limitations.

Genetic aspects

---

Harnessing the power of genomics and proteomics. Part 1: Getting to grips with genomics

Article Abstract:

Technological advancement in genomics and proteomics discovery will mean big business for the diagnostic and pharmaceutical industry. Experts are expecting the molecular diagnostic market to grow in double-digit by 2007.

United States, Pharmaceutical preparations, Pharmaceutical research

Similar abstracts:

• Abstracts: Key industry ratios and statistics. How to analyze a pharmaceutical company
• Abstracts: Searching the literature: more resources to make the purchase decision
• Abstracts: Southwest Georgia: Columbus partnership targets health status of 10-county area. HIAA President Bill Gradison
• Abstracts: The new HCFA chief. Congress grapples with Medicare reductions outside reform. Who'll make decisions? Experts debate makeup and power of a national health care board
• Abstracts: Purchasing health care services from providers with unknown altruism. GPs' payment contracts and their referral practice

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.